Search
Search Funnelback University
- Refined by:
- Date: 2022
21 -
40 of
183
search results for news |u:www.enterprise.cam.ac.uk
Fully-matching results
-
Challenges and Opportunities for Commercialisation of Research out of …
https://www.enterprise.cam.ac.uk/challenges-and-opportunities-for-commercialisation-of-research-out-of-the-social-sciences/25 Oct 2022: The push for commercialising research in the social sciences is relatively new compared to STEM subjects. ... Market-based solutions to address societal problems from academic research should not be presented as a new agenda. -
Develop a commercial opportunity – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/19 Jan 2022: become new areas of research for you. -
Impact Insight: Kalamna CIC – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-kalamna-cic/12 May 2022: Dr Khalil has spent her career researching how young Arabic learners can be engaged through a new approach to Arabic phonics. ... A licensing arrangement managed by Cambridge Enterprise now enables Kalamna CIC to launch the toolkit to an international -
NMC coating information sheet (Gre-7694-20)
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/03/NMC-coating-information-sheet-Gre-7694-20.pdf9 Feb 2022: Professor Dominic Wright leads internationally-respected research into new synthetic routes to a broad range of main group and transition metal compounds. -
Centessa Pharmaceuticals – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/centessa-pharmaceuticals-three-portfolio-companies-merge-into-a-new-pharmaceutical-giant/11 Apr 2022: 16 February 2022. Centessa Pharmaceuticals: Three portfolio companies merge into a new pharmaceutical giant. ... The new company was launched with $250 million in Series A financing—one of the biggest in recent years—led by blue-chip investors. -
Murid herpesvirus-4 (MuHV 4) Antibodies - Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/murid-herpes-virus-4-antibodies/9 May 2022: Mouse monoclonal antibodies raised against Murid herpesvirus-4 (MuHV 4) developed at the University of Cambridge. -
CRoSS Programme: Research Impact Ideation Workshop – Cambridge…
https://www.enterprise.cam.ac.uk/events/cross-programme-research-impact-ideation-workshop-2/2 Dec 2022: Join an engaged and action-focussed community as we explore new models for social science impact on global challenges. -
Cambridge Enterprise licenses unique new device for cancer diagnosis…
https://www.enterprise.cam.ac.uk/news/cambridge-enterprise-licences-unique-new-device-for-cancer-diagnosis/15 Nov 2022: 1 November 2022. Cambridge Enterprise licenses unique new device for cancer diagnosis. -
The University of Cambridge ecosystem – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/about/our-role-within-the-cambridge-ecosystem/within-the-university/20 Jul 2022: i-Teams. The i-Teams innovation programme brings together multi-disciplinary teams of post-graduates with industry mentors and real Cambridge inventions to assess the commercial viability of new technologies and ... We currently run 2 courses a term, -
Impact Insight: iKVA – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-ikva/12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: iKVA. Share:. This Impact Insight video tells the story behind the creation of iKVA. iKVA is a University of Cambridge spin-out that uses artificial intelligence (AI) to -
Science and Technology Facilities Council (STFC) Knowledge Exchange…
https://www.enterprise.cam.ac.uk/grant/science-and-technology-facilities-council-stfc-knowledge-exchange-and-commercialisation-kec-fellowships/18 Jan 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Science and Technology Facilities Council (STFC) Knowledge Exchange and Commercialisation (KEC) Fellowships. The KEC Fellowship scheme is designed to facilitate the development of -
DIOSynVax: tackling COVID-19 – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/diosynvax-tackling-covid-19/11 Apr 2022: Historically, the creation of an effective new vaccine has required years of work and hundreds of millions of pounds. -
CAM2 software for hearing aid fitting – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/reagents/cam2-software-for-hearing-aid-fitting/9 May 2022: CAM2 has been developed to provide a superior solution for the tailoring of wide-band hearing aid parameters using the audiogram alone, and is an essential new tool in the audiology -
New Head at Cambridge Enterprise Seed Funds | University of Cambridge
https://www.enterprise.cam.ac.uk/news/new-head-at-cambridge-enterprise-seed-funds/7 Apr 2022: Search. Search. New Head at Cambridge Enterprise Seed Funds. News. New Head at Cambridge Enterprise Seed Funds.. ... This news story was first published on Cambridge Enterprise's website on 06 April 2022. -
Research tools licensing – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/for-the-university/develop-a-commercial-opportunity/research-tools/19 Dec 2022: We have been licensing research tools for over a decade and can therefore fully support you through the process. -
Impact Insight: Xampla – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/video/impact-insight-xampla/12 May 2022: Mobile menu. Mobile menu. Search. back. back. back. back. back. Impact Insight: Xampla. Share:. Impact Insight video case study: Xampla. The first in our series of Impact Insight videos focuses on Xampla. It tells the exciting story of the research -
Impact Ideation Workshop: Global Sustainable Development Monday 28th…
https://www.enterprise.cam.ac.uk/wp-content/uploads/2022/12/2022.11.23_AHSS-QA-Maryam-Tanwir_Web.pdf2 Dec 2022: But unfortunately the minute that there was a change in government, the new government cut off all funding and the project was in disarray. -
Impact Insight video case study: Xampla – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/case-studies/impact-insight-video-case-study-xampla/15 Mar 2022: The first in our new series of Impact Insight videos focuses on Xampla. ... Whether you’re a University researcher or academic with a novel idea or technology, an investor keen to support innovations emerging from the University, or an external -
KARPAS 25 Human Myeloma cell line
https://www.enterprise.cam.ac.uk/reagents/karpas-25-human-myeloma-cell-line/9 May 2022: KARPAS 25 Human Myeloma cell line useful in oncology research, developed at the University of Cambridge. -
The Carbon Challenge: Daily Decarbonisation – Cambridge Enterprise
https://www.enterprise.cam.ac.uk/news/carbon-challenge-2022/28 Jan 2022: For news on upcoming Carbon Challenge events and how to register, visit our Events pages.
Search history
Recently clicked results
Recently clicked results
Your click history is empty.
Recent searches
Recent searches
Your search history is empty.